Akizawa and colleagues have investigated the beneficial effects of maintaining high Hb levels (11.0–13.0 g/dL) on kidney function and the risk of CVD in predialysis patients with CKD [17, 18]. The gene discussed is GSTM1; the disease is chronic kidney disease.